ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 64 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,281,000 | -52.3% | 5,292,156 | 0.0% | 0.46% | -28.0% |
| Q3 2018 | $6,880,000 | -3.7% | 5,292,156 | 0.0% | 0.64% | -22.1% |
| Q2 2018 | $7,144,000 | -6.9% | 5,292,156 | 0.0% | 0.82% | -26.5% |
| Q1 2018 | $7,674,000 | -35.6% | 5,292,156 | 0.0% | 1.12% | -32.8% |
| Q4 2017 | $11,907,000 | -5.3% | 5,292,156 | +43.0% | 1.66% | -20.3% |
| Q3 2017 | $12,579,000 | -4.2% | 3,699,848 | 0.0% | 2.08% | -13.7% |
| Q2 2017 | $13,134,000 | +4.4% | 3,699,848 | 0.0% | 2.42% | +0.7% |
| Q1 2017 | $12,579,000 | -26.1% | 3,699,848 | 0.0% | 2.40% | -16.9% |
| Q4 2016 | $17,019,000 | +8.5% | 3,699,848 | 0.0% | 2.88% | +7.5% |
| Q3 2016 | $15,687,000 | +76.7% | 3,699,848 | 0.0% | 2.68% | +56.4% |
| Q2 2016 | $8,880,000 | +15.1% | 3,699,848 | +125.5% | 1.72% | +7.4% |
| Q1 2016 | $7,713,000 | +19.6% | 1,641,025 | 0.0% | 1.60% | +47.1% |
| Q4 2015 | $6,449,000 | +1.5% | 1,641,025 | 0.0% | 1.09% | -13.1% |
| Q3 2015 | $6,351,000 | -15.9% | 1,641,025 | 0.0% | 1.25% | -2.8% |
| Q2 2015 | $7,549,000 | +74.7% | 1,641,025 | +156.0% | 1.29% | +78.4% |
| Q1 2015 | $4,321,000 | – | 641,025 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |